How a complex biotech company with thousands of suppliers pinpointed its most critical partners.

A biotech company wanted to focus its risk management efforts on its most vulnerable suppliers. However, with over 1,000 individual suppliers and multiple materials sourced from each, developing a robust critical list was a complex task.